The DOI matches its Crossref record; 82 of the 82 references it cites were found in a registry or an index.
Updates on the risk factors for latent tuberculosis reactivation and their managements
Open accessAbstract
The preventive treatment of latent tuberculosis infection (LTBI) is of great importance for the elimination and control of tuberculosis (TB) worldwide, but existing screening methods for LTBI are still limited in predicting the onset of TB. Previous studies have found that some high-risk factors (including human immunodeficiency virus (HIV), organ transplantation, silicosis, tumor necrosis factor-alpha blockers, close contacts and kidney dialysis) contribute to a significantly increased TB reactivation rate. This article reviews each risk factor's association with TB and approaches to address those factors. Five regimens are currently recommended by the World Health Organization, and no regimen has shown superiority over others. In recent years, studies have gradually narrowed down to the preventive treatment of LTBI for high-risk target groups, such as silicosis patients, organ-transplantation recipients and HIV-infected patients. This review discusses regimens for each target group and compares the efficacy of different regimens. For HIV patients and transplant recipients, isoniazid monotherapy is effective in treating LTBI, but for others, little evidence is available at present.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hao (2015) · doi:10.1002/14651858 · Cited by 11,321
Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent
Keane, J., Gershon, S., Wise, R. P., Mirabile-Levens, E., Kasznica, J., Schwieterman, W. D., Siegel, J. N., & Braun, M. M. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011110 · Cited by 3,710
Maini, R., St Clair, E. W., Breedveld, F., Furst, D., Kalden, J., Weisman, M., Smolen, J., Emery, P., Harriman, G., Feldmann, M., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(99)05246-0 · Cited by 2,345
Jeon, C. Y., & Murray, M. B. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050152 · Cited by 1,486
Menzies, D., Pai, M., & Comstock, G. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-5-200703060-00006 · Cited by 984
Three Months of Rifapentine and Isoniazid for Latent Tuberculosis Infection
Sterling, T. R., Villarino, M. E., Borisov, A. S., Shang, N., Gordin, F., Bliven-Sizemore, E., Hackman, J., Hamilton, C. D., Menzies, D., Kerrigan, A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1104875 · Cited by 977
Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection
(2016) · Pediatric Clinical Practice Guidelines & Policies · doi:10.1542/9781610020190-part06-targeted · Cited by 920
Interferon-γ assays in the immunodiagnosis of tuberculosis: a systematic review
Pai, M., Riley, L. W., & Colford, J. M. (2004) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(04)01206-x · Cited by 913
Treatment of latent tuberculosis infection in HIV infected persons
Akolo, C., Adetifa, I., Shepperd, S., & Volmink, J. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000171.pub3 · Cited by 713
Newsom, S. W. B. (2006) · Journal of Hospital Infection · doi:10.1016/j.jhin.2006.06.003 · Cited by 635
Solovic, I., Sester, M., Gomez-Reino, J. J., Rieder, H. L., Ehlers, S., Milburn, H. J., Kampmann, B., Hellmich, B., Groves, R., Schreiber, S., et al. (2010) · European Respiratory Journal · doi:10.1183/09031936.00028510 · Cited by 527
Iuat (1982) · Bulletin of the World Health Organization · Cited by 515
(2000) · PubMed · Cited by 486
Glucocorticoid use, other associated factors, and the risk of tuberculosis
Jick, S. S., Lieberman, E. S., Rahman, M. U., & Choi, H. K. (2006) · Arthritis Care & Research · doi:10.1002/art.21705 · Cited by 477
Rangaka, M. X., Wilkinson, K. A., Glynn, J. R., Ling, D., Menzies, D., Mwansa-Kambafwile, J., Fielding, K., Wilkinson, R. J., & Pai, M. (2012) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70210-9 · Cited by 476
Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection
Pape, J. W., Jean, S. S., Ho, J. L., Hafner, A., & Johnson, W. D. (1993) · The Lancet · doi:10.1016/0140-6736(93)91817-6 · Cited by 441
Whalen, C. C., Johnson, J. L., Okwera, A., Hom, D. L., Huebner, R., Mugyenyi, P., Mugerwa, R. D., Ellner, J. J., Nsubuga, P., Vjecha, M., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709183371201 · Cited by 396
New Regimens to Prevent Tuberculosis in Adults with HIV Infection
Martinson, N. A., Barnes, G. L., Moulton, L. H., Msandiwa, R., Hausler, H., Ram, M., McIntyre, J. A., Gray, G. E., & Chaisson, R. E. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1005136 · Cited by 385
Control and prevention of tuberculosis in the United Kingdom: Code of Practice 2000
Joint Tuberculosis Committee of the British Thoracic Society (2000) · Thorax · doi:10.1136/thorax.55.11.887 · Cited by 366
Samandari, T., Agizew, T. B., Nyirenda, S., Tedla, Z., Sibanda, T., Shang, N., Mosimaneotsile, B., Motsamai, O. I., Bozeman, L., Davis, M. K., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60204-3 · Cited by 355
Tobacco and tuberculosis: a qualitative systematic review and meta-analysis.
Slama, K., Chiang, C.-Y., Enarson, D. A., Hassmiller, K. M., Fanning, A., Gupta, P., & Ray, C. (2007) · PubMed · Cited by 339
Aguado, J. M., Herrero, J. A., Gavald??, J., Torre-Cisneros, J., Blanes, M., Ruf??, G., Moreno, A., Gurgu??, M., Hayek, M., & Lumbreras, C. (1997) · Transplantation · doi:10.1097/00007890-199705150-00015 · Cited by 338
Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection: (548072006-001)
(2000) · PsycEXTRA Dataset · doi:10.1037/e548072006-001 · Cited by 322
Latent Tuberculosis Infection in the United States
Horsburgh, C. R., & Rubin, E. J. (2011) · New England Journal of Medicine · doi:10.1056/nejmcp1005750 · Cited by 311
Hong Kong Chest Service/Tuberculosis Research Centre, M. M. R. C. (1992) · American Review of Respiratory Disease · doi:10.1164/ajrccm/145.1.36 · Cited by 304
Cattamanchi, A., Smith, R., Steingart, K. R., Metcalfe, J. Z., Date, A., Coleman, C., Marston, B. J., Huang, L., Hopewell, P. C., & Pai, M. (2011) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31820b07ab · Cited by 297
Tuberculosis Among Foreign-Born Persons in the United States
(2008) · JAMA · doi:10.1001/jama.300.4.405 · Cited by 296
Global lung health: the colliding epidemics of tuberculosis, tobacco smoking, HIV and COPD
van Zyl Smit, R. N., Pai, M., Yew, W. W., Leung, C. C., Zumla, A., Bateman, E. D., & Dheda, K. (2010) · European Respiratory Journal · doi:10.1183/09031936.00072909 · Cited by 294
Bucher, H. C., Griffith, L. E., Guyatt, G. H., Sudre, P., Naef, M., Sendi, P., & Battegay, M. (1999) · Aids · doi:10.1097/00002030-199903110-00009 · Cited by 282
Halsey, N. A., Coberly, J. S., Desormeaux, J., Losikoff, P., Atkinson, J., Moulton, L. H., Contave, M., Johnson, M., Davis, H., Geiter, L., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(97)06532-x · Cited by 270
How much isoniazid is needed for prevention of tuberculosis among immunocompetent adults?
Moulding, T. (2000) · PubMed · Cited by 268
Antirheumatic Drugs and the Risk of Tuberculosis
Brassard, P., Kezouh, A., & Suissa, S. (2006) · Clinical Infectious Diseases · doi:10.1086/506935 · Cited by 266
Diabetic Control and Risk of Tuberculosis: A Cohort Study
Leung, C. C., Lam, T. H., Chan, W. M., Yew, W. W., Ho, K. S., Leung, G. M., Law, W. S., Tam, C. M., Chan, C. K., & Chang, K. C. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwn075 · Cited by 265
Rangaka, M. X., Wilkinson, R. J., Boulle, A., Glynn, J. R., Fielding, K., van Cutsem, G., Wilkinson, K. A., Goliath, R., Mathee, S., Goemaere, E., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60162-8 · Cited by 262
Metcalfe, J. Z., Everett, C. K., Steingart, K. R., Cattamanchi, A., Huang, L., Hopewell, P. C., & Pai, M. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir410 · Cited by 257
Tuberculosis in patients with end-stage renal disease
Andrew, O. T., Schoenfeld, P. Y., Hopewell, P. C., & Humphreys, M. H. (1980) · The American Journal of Medicine · doi:10.1016/0002-9343(80)90166-7 · Cited by 241
A Trial of Mass Isoniazid Preventive Therapy for Tuberculosis Control
Churchyard, G. J., Fielding, K. L., Lewis, J. J., Coetzee, L., Corbett, E. L., Godfrey-Faussett, P., Hayes, R. J., Chaisson, R. E., & Grant, A. D. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1214289 · Cited by 238
The epidemiology of tuberculosis in gold miners with silicosis.
Cowie, R. L. (1994) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.150.5.7952577 · Cited by 236
(1982) · Europe PMC (PubMed Central) · Cited by 236
How much isoniazid is needed for prevention of tuberculosis among immunocompetent adults?
Gw, C. (1999) · PubMed · Cited by 233
Zolopa, A. R. (1994) · JAMA · doi:10.1001/jama.272.6.455 · Cited by 225
Latent TB Infection Treatment Acceptance and Completion in the United States and Canada
Horsburgh, C. R., Goldberg, S., Bethel, J., Chen, S., Colson, P. W., Hirsch-Moverman, Y., Hughes, S., Shrestha-Kuwahara, R., Sterling, T. R., Wall, K., et al. (2010) · Chest · doi:10.1378/chest.09-0394 · Cited by 224
Sutherland, I. (1976) · PubMed · Cited by 210
Graham, N. M. H. (1992) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1992.03480030047035 · Cited by 204
Tuberculosis in patients receiving anti-TNF agents despite chemoprophylaxis.
Sichletidis, L. T., Settas, L., Spyratos, D. G., Chloros, D., & Patakas, D. (2006) · PubMed · Cited by 198
Menzies, D., Long, R., Trajman, A., Dion, M.-J., Yang, J., Al Jahdali, H., Memish, Z., Khan, K., Gardam, M., Hoeppner, V., et al. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-10-200811180-00003 · Cited by 187
THE HIGH INCIDENCE OF TUBERCULOSIS AMONG RENAL TRANSPLANT RECIPIENTS IN INDIA
Sakhuja, V., Jha, V., Varma, P. P., Joshi, K., & Chugh, K. S. (1996) · Transplantation · doi:10.1097/00007890-199601270-00008 · Cited by 186
Incidence of pulmonary tuberculosis among diabetics
Kim, S. J., Hong, Y. P., Lew, W. J., Yang, S. C., & Lee, E. G. (1995) · Tubercle and Lung Disease · doi:10.1016/0962-8479(95)90529-4 · Cited by 181
Catanzaro, A. (1982) · American Review of Respiratory Disease · doi:10.1164/arrd.1982.125.5.559 · Cited by 177
Menzies, D., Dion, M.-J., Rabinovitch, B., Mannix, S., Brassard, P., & Schwartzman, K. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200404-478oc · Cited by 168
Lichtenstein, I. H., & MacGregor, R. R. (1983) · Clinical Infectious Diseases · doi:10.1093/clinids/5.2.216 · Cited by 166
Priorities for Screening and Treatment of Latent Tuberculosis Infection in the United States
Linas, B. P., Wong, A. Y., Freedberg, K. A., & Horsburgh, C. R. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201101-0181oc · Cited by 163
The Risk of Tuberculosis Disease Among Persons With Diabetes Mellitus: A Prospective Cohort Study
Baker, M. A., Lin, H.-H., Chang, H., & Murray, M. B. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cir939 · Cited by 137
Harries, A. D., Lin, Y., Satyanarayana, S., Lönnroth, K., Li, L., Wilson, N. C., Chauhan, L. S., Zachariah, R., Baker, M. A., Jeon, C. Y., et al. (2011) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.11.0503 · Cited by 135
Grant, A. D., Charalambous, S., Fielding, K., Day, J. H., Corbett, E. L., Chaisson, R. E., Cock, K. M. D., Hayes, R., & Churchyard, G. (2005) · JAMA · doi:10.1001/jama.293.22.2719 · Cited by 126
Altet, M. N., Alcaide, J., Plans, P., et al. (1996) · Tubercle and Lung Disease · doi:10.1016/s0962-8479(96)90052-0 · Cited by 119
Ai, J., Zhang, S., Ruan, Q., Yu, Y., Zhang, B., Liu, Q., & Zhang, W. (2015) · The Journal of Rheumatology · doi:10.3899/jrheum.150057 · Cited by 114
Self-citationTreatment for LTBI in contacts of MDR-TB patients, Federated States of Micronesia, 2009–2012
Bamrah, S., Brostrom, R. J., Fred, D., Setik, L., Song, R., Kawamura, L. M., Heetderks, A., & Mase, S. (2014) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.13.0028 · Cited by 113
Tuberculosis morbidity of young men in relation to tuberculin sensitivity and body build.
Palmer, C. E., Jablon, S., & Edwards, P. Q. (1957) · PubMed · doi:10.1164/artpd.1957.76.4.517 · Cited by 110
Occupational Tuberculous Infections among Pulmonary Physicians in Training
Malasky, C., Jordan, T. J., Potulski, F., & Reichman, L. B. (1990) · American Review of Respiratory Disease · doi:10.1164/ajrccm/142.3.505 · Cited by 109
Costs and Cost-effectiveness of Four Treatment Regimens for Latent Tuberculosis Infection
Holland, D. P., Sanders, G. D., HAMILTON, C. D., & Stout, J. E. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200901-0153oc · Cited by 108
Sterling, T. R., Sterling, T. R., Moro, R. N., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ323 · Cited by 108
Risk of tuberculosis among people with diabetes mellitus: an Australian nationwide cohort study
Dobler, C. C., Flack, J. R., & Marks, G. B. (2012) · BMJ Open · doi:10.1136/bmjopen-2011-000666 · Cited by 108
Wallace, R., & Wallace, D. (1997) · BMJ · doi:10.1136/bmj.314.7090.1341 · Cited by 104
Evaluation of Immigrant Tuberculosis Screening in Industrialized Countries
Pareek, M., Baussano, I., Abubakar, I., Dye, C., & Lalvani, A. (2012) · Emerging infectious diseases · doi:10.3201/eid1809.120128 · Cited by 98
Interpretation of the tuberculin skin test
Rose, D. N., Schechter, C. B., & Adler, J. J. (1995) · Journal of General Internal Medicine · doi:10.1007/bf02602749 · Cited by 95
Tuberculosis in Renal Transplant Recipients: The Evidence for Prophylaxis
Currie, A., Knight, S. R., & Morris, P. J. (2010) · Transplantation · doi:10.1097/tp.0b013e3181ecea8d · Cited by 95
Prospective randomized control trial of isoniazid chemoprophylaxis during renal replacement therapy
Vikrant, S., Agarwal, S. K., Gupta, S. K., Bhowmik, D. M., Tiwari, S. C., Dash, S., Guleria, S., & Mehta, S. (2005) · Transplant Infectious Disease · doi:10.1111/j.1399-3062.2005.00103.x · Cited by 87
Preventive chemotherapy. Where has it got us? Where to go next?
Landry, J., & Menzies, D. (2008) · PubMed · Cited by 79
John, G. T., Thomas, P. P., Thomas, M., Jeyaseelan, L., Jacob, C. K., & Shastry, J. C. M. (1994) · PubMed · Cited by 78
John, G. T., Thomas, P. P., Thomas, M., Jeyaseelan, L., Jacob, C. K., & Shastry, J. C. M. (1994) · Transplantation · doi:10.1097/00007890-199457110-00029 · Cited by 78
Nardell, E. A. (1990) · American Review of Respiratory Disease · doi:10.1164/ajrccm/142.3.501 · Cited by 49
Use of isoniazid chemoprophylaxis in renal transplant recipients
Naqvi, R., Naqvi, A., Akhtar, S., Ahmed, E., Noor, H., Saeed, T., Akhtar, F., & Rizvi, A. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp489 · Cited by 49
van der Werf, M. J., Langendam, M. W., Sandgren, A., et al. (2012) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.11.0437 · Cited by 48
Tobacco exposure and susceptibility to tuberculosis: Is there a smoking gun?
Chan, E. D., Kinney, W. H., Honda, J. R., Bishwakarma, R., Gangavelli, A., Mya, J., Bai, X., & Ordway, D. J. (2014) · Tuberculosis · doi:10.1016/j.tube.2014.08.010 · Cited by 38
Chu, H., Shih, C.-J., Lee, Y.-J., Kuo, S., Hsu, Y.-T., Ou, S., Shih, Y.-N., Tarng, D., Li, S., Chen, Y., et al. (2014) · Journal of Infection · doi:10.1016/j.jinf.2014.06.019 · Cited by 34
Treatment guidelines for latent tuberculosis infection.
(2014) · PubMed · Cited by 29
Diabetes mellitus and pulmonary tuberculosis
Boucot, K. R. (1957) · Journal of Chronic Diseases · doi:10.1016/0021-9681(57)90007-3 · Cited by 27
Tuberculosis in UK prisoners: a challenge for control
Anderson, C. S., Story, A., Brown, T., Drobniewski, F. A., & Abubakar, I. I. (2010) · Journal of Epidemiology & Community Health · doi:10.1136/jech.2009.094375 · Cited by 27
Cited by
Drain, P. K., Bajema, K. L., Dowdy, D., Dheda, K., Naidoo, K., Schumacher, S. G., Ma, S., Meermeier, E., Lewinsohn, D. M., & Sherman, D. R. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00021-18 · Cited by 565
Anti-tuberculosis treatment strategies and drug development: challenges and priorities
Dartois, V. A., & Rubin, E. J. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00731-y · Cited by 490
Bacterial Longevity Requires Protein Synthesis and a Stringent Response
Yin, L., Ma, H., Nakayasu, E. S., Payne, S. H., Morris, D. R., & Harwood, C. S. (2019) · mBio · doi:10.1128/mbio.02189-19 · Cited by 31
Long‐term exposure to indoor air pollution and risk of tuberculosis
Patel, V., Foster, A., Salem, A., Kumar, A., Kumar, V., Biswas, B., Mirsaeidi, M., & Kumar, N. (2021) · Indoor Air · doi:10.1111/ina.12756 · Cited by 27
Bacterial longevity requires protein synthesis and a stringent response
Yin, L., Ma, H., Nakayasu, E. S., Payne, S. H., Morris, D. R., & Harwood, C. S. (2019) · doi:10.1101/628826
Metadata
- Authors
- Ai, J.-W., Ruan, Q.-L., Liu, Q.-H., & Zhang, W.-H.
- Venue
- Emerging Microbes & Infections
- Publisher
- Informa UK Limited
- Published
- 2016-01
- Volume
- 5
- Issue
- 1
- Pages
- 1-8
- ISSN
- 2222-1751 (ISSN-L)
- OpenAlex
- W2273040868
- Cited by
- 298
- References
- 82
- FWCI
- 23.52
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.